Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-19T23:53:56.713Z Has data issue: false hasContentIssue false
  • English
  • Français

Prescribing donepezil in clinical practice

Published online by Cambridge University Press:  03 January 2018

M. A. Watts-Tobin  and
N. Horn
M. A. Watts-Tobin
Affiliation:
Department of Old Age Psychiatry, Lancaster Moor Hospital, Lancaster LA1 3JR
N. Horn
Affiliation:
University of Manchester Neuroscience and Psychiatry Unit, Stopford Building, Oxford Road, Manchester MI3 9PT
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 175 , Issue 4 , October 1999 , pp. 393
Copyright
Copyright © 1999 The Royal College of Psychiatrists 

References

Burns, A., Russell, E. & Page, S. (1999a) New drugs for Alzheimer's disease. British Journal of Psychiatry, 175, 476–479.CrossRefGoogle Scholar
Burns, A., Rossor, H., Hecker, J., et al and the International Donepezil Study Group (1999b) The effects of donepezil in Alzheimer's disease – results from a multinational trial. Dementia ana Geriatric Cognitive Disorders, 10, 237–244.CrossRefGoogle ScholarPubMed
Leber, P. (1990) Guidelines for the Clinical Evaluation of Antidementia Drugs. Washington, DC: Food and Drug Administration.Google Scholar
Roth, M., Tym, E., Mountjoy, C. Q., et al (1984) CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry, 149, 698–709.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.